• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    More On OXB.L

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Oxford BioMedica PLC (OXB.L)

    -LSE
    10.25 Down 0.25(2.38%) May 22, 11:35AM EDT
    Add to Portfolio
    Prev Close:10.50
    Open:10.50
    Bid:10.00
    Ask:10.50
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:10.25 - 10.75
    52wk Range:1.91 - 13.38
    Volume:1,321,008
    Avg Vol (3m):6,919,330
    Market Cap:263.19M
    P/E (ttm):N/A
    EPS (ttm):-0.00
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in GBp.

    Headlines

    • No Headlines available for OXB.L at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,972.88
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.25
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Oxford BioMedica plc, a biopharmaceutical company, develops gene-based medicines and therapeutic vaccines. Its LentiVector platform technology integrates genes into non-dividing cells in the brain and the eye, as well as accommodates multiple ther... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback